Pulsatile gonadotrophin secretion in women with polycystic ovary syndrome after gonadotrophin-releasing hormone agonist treatment.

By Cheung A P   Lu J K   Chang R J  

Human Reproduction, Vol. 12, Iss. 6, 1997-06 ,pp. : 1156-1164

Oxford University Press

Access to resources Recommend Favorite

The use of long- and short-acting forms of gonadotrophin-releasing hormone analogues in women undergoing oocyte donation

By Neuspiller F   Levy M   Remohi J   Ruiz A   Simon C   Pellicer A  

Human Reproduction, Vol. 13, Iss. 5, 1998-05 ,pp. : 1148-1151

Oxford University Press

Access to resources Recommend Favorite

Effect of gonadotrophin-releasing hormone agonist treatment on growth hormone secretion in women with polycystic ovarian syndrome

By Kaltsas T  

Human Reproduction, Vol. 13, Iss. 1, 1998-01 ,pp. : 22-26

Oxford University Press

Access to resources Recommend Favorite

Gonadotrophin-releasing hormone analogues and endometriosis: current strategies and new insights

By Abu Hashim Hatem  

Gynecological Endocrinology, Vol. 28, Iss. 4, 2012-04 ,pp. : 314-321

Informa Healthcare

Access to resources Recommend Favorite

Triggering the final stage of ovulation using gonadotrophin-releasing hormone analogues: effective dose, prevention of ovarian hyperstimulation syndrome and the luteal phase

By Ben-Arie A.   Weissman A.   Shoham Z.  

Human Reproduction, Vol. 11, Iss. 6, 1996-06 ,pp. : 1146-1148

Oxford University Press

Access to resources Recommend Favorite